CGEN Price Targets and Analyst Ratings NASDAQ:CGEN
CGEN Forecast. What You Should Know.
CGEN Historical Ratings and Targets
About Compugen Ltd.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.